TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Orifarm Generics A/S
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
3,607,628
|
3,182,985
|
3,104,952 |
| Earnings before taxes |
118,625
|
119,494
|
104,056 |
| Total assets |
1,601,772
|
2,058,149
|
2,013,038 |
| Current assets |
1,513,580
|
1,983,388
|
1,942,220 |
| Current liabilities |
728,457
|
1,305,554
|
1,351,369 |
| Equity capital |
853,800
|
736,439
|
646,060 |
| - share capital |
1,540
|
1,489
|
1,496 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
53.3%
|
35.8%
|
32.1% |
| Turnover per employee |
24,051
|
21,220
|
20,700 |
| Profit as a percentage of turnover |
3.3%
|
3.8%
|
3.4% |
| Return on assets (ROA) | |||
| Current ratio |
207.8%
|
151.9%
|
143.7% |
| Return on equity (ROE) |
13.9%
|
16.2%
|
16.1% |
| Change turnover |
315,760
|
93,941
|
475,110 |
| Change turnover % |
10%
|
3%
|
18% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.